Related Experiment Video

Updated: Apr 12, 2026

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

1.9K

The role of BRAF in the pathogenesis of thyroid carcinoma

Dan-Dan Li, Yi-Feng Zhang, Hui-Xiong Xu1

  • 1Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tenth People's Hospital of Tongji University, Shanghai 200072, China, huixiong_xu@163.com.

Frontiers in Bioscience (Landmark Edition)
|May 12, 2015
PubMed

Insights

The BRAF V600E mutation drives cancer by activating the MAPK pathway. Detecting this mutation is key for understanding thyroid cancer progression and developing targeted BRAF inhibitor therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • BRAF is a key kinase in the MAPK pathway, crucial for cell signaling.
  • BRAF mutations, particularly V600E, are implicated in various human cancers.
  • The BRAF V600E mutation leads to uncontrolled kinase activity, promoting cancer development.

Purpose of the Study:

  • To review the function of BRAF and its mutations in thyroid cancer.
  • To explore the prognostic value of BRAF V600E in thyroid carcinoma.
  • To discuss the role of BRAF mutations in the tumor microenvironment and potential therapeutic strategies.

Main Methods:

  • Literature review of BRAF function, mutations, and cancer relevance.
  • Analysis of studies correlating BRAF V600E with thyroid cancer phenotypes.
  • Exploration of drug design principles targeting oncogenic BRAF.

Main Results:

  • The BRAF V600E mutation is a significant driver in papillary thyroid cancer (PTC) and anaplastic thyroid cancer (ATC).
  • This mutation is associated with aggressive, iodine-resistant thyroid cancer phenotypes.
  • BRAF V600E detection is vital for identifying new therapeutic targets.

Conclusions:

  • BRAF V600E is a critical oncogenic driver in thyroid cancer.
  • Understanding BRAF's role facilitates the development of targeted therapies.
  • BRAF mutation status offers prognostic insights and guides treatment decisions.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.8K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K